Study guide
1.3 Anaphylaxis & Acute Airway Emergencies
Professional and Linguistic Assessments Board Part 1 PLAB 1
Track your progress as you read
Finished sections get a check mark.
1 Introduction
About the PLAB 1 Exam
2 Chapter 1: Acute Medicine, Resuscitation & Clinical Emergencies
1.1 The ABCDE Approach, Adult Resuscitation & Shock 1.2 Sepsis, Sepsis Six Protocol & Septic Shock 1.3 Anaphylaxis & Acute Airway Emergencies 1.4 Clinical Toxicology & Acute Poisoning 1.5 Major Trauma, Head Injury, Burns & Environmental Emergencies
3 Chapter 2: Cardiovascular Medicine & Vascular Disorders
2.1 Acute Coronary Syndromes (STEMI & NSTEMI/Unstable Angina) 2.2 Heart Failure & Cardiogenic Shock 2.3 Cardiac Arrhythmias & Syncope 2.4 Hypertension, Valvular Heart Disease & Aortic Emergencies 2.5 Infective Endocarditis, Pericardial Disease, Myocarditis & Cardiomyopathies 2.6 Peripheral Arterial Disease, Aortic Aneurysm & Venous Disease
4 Chapter 3: Respiratory Medicine
3.1 Asthma: Diagnostic Criteria, Chronic Stepping & Acute Exacerbations 3.2 COPD: Staging, Long-Term Management & Acute Exacerbations 3.3 Pneumonia & Lower Respiratory Tract Infections 3.4 Venous Thromboembolism, Pleural Disease & Pneumothorax 3.5 Lung Cancer, Interstitial & Suppurative Lung Disease, Sleep Apnoea & Respiratory Failure
5 Chapter 4: Gastroenterology, Hepatobiliary & General Surgery
4.1 Upper Gastrointestinal Bleeding & Dyspepsia 4.2 Lower Gastrointestinal Bleeding, IBD & Colorectal Malignancy 4.3 Acute Abdomen, Bowel Obstruction & Perforation 4.4 Hepatobiliary Disease, Cirrhosis & Acute Pancreatitis 4.5 Functional, Malabsorptive & Infective Bowel Disorders, Anorectal Disease, Hernias & MASLD
6 Chapter 5: Renal Medicine, Urology & Fluid/Electrolyte Balance
5.1 Acute Kidney Injury & KDIGO Staging 5.2 Chronic Kidney Disease & Glomerular Disorders 5.3 Electrolyte Emergencies: Potassium, Sodium & Calcium 5.4 Urology: Urinary Tract Infections, Renal Colic & Urinary Retention 5.5 Urological Cancers, Prostate Disease & Scrotal Emergencies
7 Chapter 6: Endocrinology & Metabolic Medicine
6.1 Diabetes Mellitus: Diagnostic Criteria & Chronic Management 6.2 Diabetic Emergencies: DKA & Hyperosmolar Hyperglycaemic State 6.3 Thyroid Disorders: Hypothyroidism, Thyrotoxicosis & Thyroid Storm 6.4 Adrenal & Pituitary Disorders: Addisonian Crisis & Pituitary Disease
8 Chapter 7: Neurology & Neurosciences
7.1 Acute Stroke, TIA & Intracranial Haemorrhage 7.2 Acute & Chronic Headaches, Giant Cell Arteritis & CNS Infections 7.3 Seizures, Status Epilepticus & Epilepsy Management 7.4 Neuromuscular Disorders & Movement Disorders 7.5 Raised Intracranial Pressure, Brain Tumours, Cranial Nerve Lesions & Spinal Cord Disorders
9 Chapter 8: Psychiatry & Mental Health
8.1 Affective Disorders: Depression, Bipolar Disorder & Suicide Risk Assessment 8.2 Psychosis, Schizophrenia & Acute Agitation 8.3 Cognitive Disorders, Substance Misuse & the Mental Health Act 8.4 Anxiety Disorders, OCD, PTSD, Eating Disorders, Personality Disorders & Somatic Presentations 8.5 Perinatal, Child & Adolescent and Neurodevelopmental Mental Health
10 Chapter 9: Obstetrics, Gynaecology & Sexual Health
9.1 Early Pregnancy: Miscarriage & Ectopic Pregnancy 9.2 Antenatal & Peripartum Emergencies: Pre-Eclampsia & Haemorrhage 9.3 Common Gynaecological Presentations & Gynaecological Oncology 9.4 Contraception, Emergency Contraception & Sexually Transmitted Infections 9.5 Routine Antenatal Care, Labour & Obstetric Emergencies 9.6 Menopause & HRT, Subfertility, Prolapse & Urinary Incontinence
11 Chapter 10: Paediatrics & Child Health
10.1 The Febrile Child, Sepsis & Meningococcal Disease 10.2 Paediatric Respiratory Distress: Croup, Bronchiolitis & Wheeze 10.3 Paediatric Abdominal Emergencies, Dehydration & Neonatal Jaundice 10.4 Child Safeguarding, Non-Accidental Injury & Developmental Milestones 10.5 Neonatology & Congenital Heart Disease 10.6 Paediatric Orthopaedics, Growth, Childhood Cancer & Common Chronic Problems
12 Chapter 11: Musculoskeletal Medicine & Rheumatology
11.1 Inflammatory Arthropathies & Connective Tissue Diseases 11.2 Crystal Arthropathies (Gout & Pseudogout) & Septic Arthritis 11.3 Osteoporosis, Common Fractures & Orthopaedic Emergencies 11.4 Osteoarthritis, Low Back Pain, Polymyalgia Rheumatica, Fibromyalgia & Soft Tissue Disorders
13 Chapter 12: Dermatology, ENT & Ophthalmology
12.1 Common Dermatoses & Dermatological Emergencies 12.2 ENT Presentations: Infections, Epistaxis, Vertigo, Hearing Loss & Head and Neck Lumps 12.3 The Acute Red Eye: Glaucoma, Uveitis & Keratitis 12.4 Sudden & Gradual Vision Loss, Retinal Disorders & the Visual Pathway 12.5 Skin Infections, Infestations, Childhood Rashes & Skin Cancer
14 Chapter 13: Haematology, Oncology & Palliative Care
13.1 Anaemias & Blood Transfusion Medicine 13.2 Haematological Malignancies: Leukaemias, Lymphomas & Myeloma 13.3 Haemostasis, Coagulation Disorders & Anticoagulant Reversal 13.4 Oncological Emergencies & Palliative Symptom Management 13.5 Breast Disease, Cancer Screening & Suspected Cancer Referral
15 Chapter 14: Perioperative Care, Safe Prescribing & Clinical Pharmacology
14.1 Preoperative Assessment & Perioperative Medication Management 14.2 Postoperative Complications & Fluid Therapy 14.3 High-Risk Medications & Therapeutic Drug Monitoring 14.4 Safe Prescribing Principles & Antimicrobial Stewardship
16 Chapter 15: Medical Ethics, Law & UK Clinical Practice
15.1 GMC Good Medical Practice, Professionalism, Teamwork & Quality Improvement 15.2 Consent, Capacity & the Mental Capacity Act 2005 15.3 Confidentiality, Statutory Reporting & DVLA Regulations 15.4 End-of-Life Decisions, DNACPR, Organ Donation, Adult Safeguarding & Domestic Abuse
17 Chapter 16: Infectious Diseases, Travel Medicine & Infection Prevention
16.1 Tuberculosis, HIV, Hepatitis B & C and Needlestick Injuries 16.2 Fever in the Returning Traveller, Zoonoses, Notifiable Diseases & Infection Prevention
18 Chapter 17: Older Adults, Population Health, Genetics & Clinical Imaging
17.1 Frailty, Falls, Polypharmacy, Continence & Pressure Ulcers 17.2 Medical Statistics, Diagnostic Tests & Critical Appraisal 17.3 Public Health, Screening Principles, Health Inequalities & Health Promotion 17.4 Genetics, Genomics & Pharmacogenomics 17.5 Clinical Imaging: Choosing Tests, Radiation Safety & Interpreting X-rays
1.3 Anaphylaxis & Acute Airway Emergencies
Key Takeaways Explain This Topic AI
Anaphylaxis is an acute, life-threatening systemic hypersensitivity reaction characterized by rapidly progressive Airway, Breathing, or Circulation compromise, usually accompanied by mucosal or cutaneous features.
Intramuscular adrenaline 1:1000 (1 mg/mL) injected into the anterolateral mid-thigh is the immediate first-line drug: 500 micrograms for adults (>12 yr), 300 micrograms for children aged 6–12 yr, and 150 micrograms for children aged 6 mo–6 yr.
Antihistamines and corticosteroids are not first-line: the RCUK 2021 guideline no longer advises routine corticosteroids and prefers a non-sedating oral antihistamine once the patient is stable; neither may delay adrenaline or airway management.
Serial mast cell tryptase measurements should be obtained at presentation, at 1–2 hours post-reaction, and at least 24 hours later to establish the patient's true baseline.
Last updated: October 2026
Anaphylaxis & Acute Airway Emergencies
Anaphylaxis is a severe, life-threatening, generalised or systemic hypersensitivity reaction characterized by rapidly developing airway compromise, breathing difficulty, and/or circulatory collapse. Prompt administration of intramuscular adrenaline is the single most critical intervention to prevent fatal asphyxiation or cardiovascular collapse.
Diagnostic Criteria & Clinical Presentation
According to Resuscitation Council UK (RCUK) guidelines, anaphylaxis is likely when a patient presents with sudden onset and rapid progression of symptoms involving:
A – Airway Problems: Pharyngeal or laryngeal oedema, hoarse voice, stridor, tongue and lip swelling, difficulty swallowing.
B – Breathing Problems: Bronchospasm, expiratory wheeze, tachypnoea, intercostal recession, exhaustion, hypoxaemia (cyanosis).
C – Circulation Problems: Profound hypotension (SBP <90 mmHg or faintness), tachycardia (or relative bradycardia), cold clammy skin, pallor, dizziness, cardiac arrest.
Warning
Skin and Mucosal Signs Are NOT Obligatory: While urticaria, generalized erythema, angioedema, and intense pruritus occur in over 80% of anaphylactic reactions, up to 20% of severe or rapidly fatal presentations present with isolated circulatory collapse or acute airway obstruction without visible cutaneous manifestations. Never withhold adrenaline because a rash is absent!
- Immediate Resuscitation & Adrenaline Dosing
- Patient Positioning
Hypotension/Circulatory Collapse: Lie the patient flat and elevate the legs to enhance venous return to the heart.
Airway/Breathing Distress: Patients struggling to breathe may prefer sitting upright, but monitor blood pressure closely.
Late Pregnancy: Position in the left lateral tilt position to prevent aortocaval compression by the gravid uterus.
Fatal Pitfall: Never allow the patient to sit up suddenly, stand, or walk. Sudden standing causes acute vena caval pooling, fatal loss of cardiac filling pressure (empty ventricle syndrome), and pulseless electrical activity arrest.
Intramuscular Adrenaline Dosing (1:1000 = 1 mg/mL)
Adrenaline acts rapidly to reverse peripheral vasodilation (alpha-1 agonism), relieve bronchospasm and laryngeal oedema (beta-2 agonism), and suppress mast cell degranulation.
- Patient Age / Category IM Adrenaline (1:1000) Dose Volume of 1:1000 Solution
- Adult and Child > 12 years 500 micrograms 0.5 mL
- Child 6 – 12 years 300 micrograms 0.3 mL
- Child 6 months – 6 years 150 micrograms 0.15 mL
- Infant < 6 months 100 – 150 micrograms 0.1 – 0.15 mL
Injection Site: The anterolateral aspect of the middle third of the thigh (vastus lateralis) . The high vascularity of this muscle bed achieves significantly faster peak plasma concentrations than deltoid or subcutaneous routes.
Repeat Dosing: If there is no clinical improvement or if the patient deteriorates, repeat the IM dose after 5 minutes .
Fluid Resuscitation & Refractory Anaphylaxis
Massive capillary endothelial permeability causes rapid loss of up to 35% of circulating intravascular volume into the interstitial space within minutes. Administer an immediate rapid IV fluid challenge of 500–1000 mL of balanced crystalloid in adults ( 10 mL/kg in children, per RCUK 2021).
Refractory Anaphylaxis: Defined as anaphylaxis that requires ongoing treatment despite two appropriate doses of intramuscular adrenaline. Management requires immediate critical care escalation, expert airway management, and initiation of a titrated intravenous adrenaline infusion (typically 0.1 micrograms/kg/min) by trained critical care personnel under continuous ECG and arterial line monitoring. Intravenous adrenaline boluses are strictly avoided outside cardiac arrest due to high risks of fatal ventricular tachyarrhythmias and myocardial infarction.
Second-Line Adjunctive Therapies & Clarifications
In older protocols, antihistamines and corticosteroids were routinely administered alongside adrenaline. The RCUK 2021 anaphylaxis guideline explicitly demotes these drugs to secondary, non-urgent roles:
Antihistamines (third-line): Once the patient is stable, a non-sedating oral antihistamine (e.g. cetirizine) is preferred over chlorphenamine for skin symptoms (parenteral chlorphenamine can worsen hypotension). Antihistamines treat pruritus, urticaria and erythema. They have no effect on life-threatening laryngeal oedema or shock. Antihistamines must never delay adrenaline administration.
Corticosteroids (e.g., Hydrocortisone 200 mg IV in adults): Historically administered to prevent late-phase biphasic anaphylactic reactions. However, systematic reviews demonstrate no robust evidence of clinical benefit. RCUK guidelines state corticosteroids are no longer routinely recommended for the acute management of anaphylaxis.
Inhaled Bronchodilators (Salbutamol): Useful adjunctive therapy for persistent lower airway bronchospasm that persists after IM adrenaline has stabilized systemic hemodynamics.
Diagnostic Confirmation: Mast Cell Tryptase
Serum mast cell tryptase is a neutral protease stored inside secretory granules of mast cells. A marked elevation confirms systemic mast cell degranulation.
Timing of Blood Sample Clinical Purpose
Sample 1: Immediate Drawn as soon as practical after starting resuscitation (do not delay treatment).
Sample 2: 1 to 2 Hours Drawn 1–2 hours post-onset of symptoms (corresponds to peak circulating tryptase levels).
Sample 3: ≥ 24 Hours Drawn at least 24 hours later (or in follow-up allergy clinic) to establish the true baseline level.
Discharge Planning & Auto-Injectors
Observation Period (RCUK 2021, timed from resolution of symptoms): fast-track discharge after 2 hours can be considered after a good response (within 5–10 minutes) to a single dose of adrenaline given within 30 minutes of onset, with complete resolution, unused adrenaline auto-injectors and training, and adequate supervision; observe for at least 6 hours if two doses of IM adrenaline were needed or there is a previous biphasic reaction; observe for at least 12 hours after a severe reaction needing more than two doses, with severe asthma or severe respiratory compromise, possible continuing absorption of the allergen (e.g. slow-release medicines), a late-night presentation, or poor access to emergency care.
Discharge Essentials: Prescribe two adrenaline auto-injectors (AAIs) (e.g., 300 mcg or 500 mcg devices), provide face-to-face device training with a trainer kit, supply a written anaphylaxis action plan, and make an urgent referral to a specialist allergy clinic.
Acute Upper Airway Emergencies
Emergency Condition Pathophysiology & Presentation Immediate Clinical Management
Foreign Body Airway Obstruction (FBAO) Sudden choking while eating; severe: unable to speak/cough, clutching neck, silent stridor, cyanosis Conscious: 5 sharp back blows between scapulae, followed by 5 abdominal thrusts (chest thrusts in infants/pregnant). Unconscious: Call 2222; commence CPR 30:2 immediately.
Acute Epiglottitis Rapid supraglottic inflammation (Haemophilus influenzae, Streptococcus); sore throat, high fever, drooling, dysphagia, muffled voice, tripod position , inspiratory stridor DO NOT examine the throat with a tongue depressor (precipitates fatal complete laryngospasm). Keep patient calm with parents/carers. Call senior anaesthetist and ENT surgeon immediately for emergency fiberoptic intubation in the operating theatre. IV ceftriaxone.
Ludwig's Angina Rapidly spreading cellulitis of bilateral submandibular and sublingual spaces, typically from infected lower molars (2nd/3rd); "woody" brawny floor-of-mouth swelling, protruding tongue, neck crepitus, airway occlusion Urgent senior airway call; awake fiberoptic intubation or awake tracheostomy before complete occlusion. IV broad-spectrum antibiotics (co-amoxiclav + metronidazole or piperacillin-tazobactam) and surgical incision and drainage.